Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...
In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, ...
Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...
The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...
Dr. Jay Bhattacharya, a professor of medicine at Stanford University, gained prominence during the Covid pandemic when he ...
A relatively sedate Senate Health, Education, Labor and Pensions Committee confirmation hearing for National Institutes of Health Director-nominee Dr. Jay Bhattacharya revealed his five goals to ...
Public health experts discuss lessons learned from the U.S. response to the COVID pandemic, on topics ranging from school ...
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback